Chester County News and Community Website
WILMINGTON, DE — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) has completed commercial-scale manufacturing validation for its preservative-free injectable ketamine, positioning the company to begin supplying U.S. hospitals and clinics if the …
NRx Clears Manufacturing Hurdle for Ketamine FDA Review Read More WILMINGTON, DE — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) is approaching a November 10 federal regulatory decision on its preservative-free ketamine product after the Food and Drug Administration requested only minor …
NRx Nears FDA Decision on U.S.-Made Ketamine Product Read More WILMINGTON, DE — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) received a revised Nov. 10 regulatory goal date for its preservative-free ketamine application after the U.S. Food and Drug Administration reclassified a …
NRx Gets Earlier FDA Goal Date for Ketamine Application Read More WILMINGTON, DE — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) moved closer to potential commercialization of its preservative-free ketamine product in the first quarter as the company scaled manufacturing, advanced multiple FDA …
NRx Pushes Toward Ketamine Launch Amid FDA Review Read More WILMINGTON, DE — NRx Pharmaceuticals (Nasdaq: NRXP) has placed its first commercial manufacturing order for a preservative-free ketamine product ahead of a potential U.S. approval expected under the Generic Drug …
NRx Begins Ketamine Production Ahead of FDA Decision Read More
At 11:00 p.m., he did what Americans are told to do in their darkest moments:
When a Call for Help Becomes a Police Matter Read More WILMINGTON, DE — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) recently received preliminary feedback from the U.S. Food and Drug Administration on labeling for its preservative-free ketamine product, as the company continues …
NRx Receives FDA Feedback on Ketamine Drug Labeling Read More WILMINGTON, DE — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) said the U.S. Food and Drug Administration has not identified bioequivalence deficiencies in its abbreviated new drug application for a preservative-free ketamine …
NRx Says FDA Finds No Bioequivalence Issues in Ketamine Filing Read More
PHILADELPHIA, PA — U.S. Customs and Border Protection officers in Philadelphia have intercepted six additional ketamine smuggling attempts originating in Europe, uncovering concealed shipments of the dangerous drug hidden inside …
Hidden in Plain Sight: CBP Busts Six Ketamine Smuggling Attempts at Philly Hub Read More WILMINGTON, DE — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) announced it has received U.S. Food and Drug Administration (FDA) approval of a Suitability Petition allowing the company to proceed with its …
NRx Wins FDA Nod to Advance Preservative-Free Ketamine Product KETAFREE Read More